ICON, which builds homes using 3D printing, has closed on $56 million in Series C funding co-led by Norwest Venture Partners ...

Gas station and convenience store supplier Global Partners LP said this week it will move its headquarters from Waltham to Newton in late 2026, with a 12-year lease for 100,419 square feet.

Adam Gilden, MD, MSCE, is an associate director of the Obesity Medicine Fellowship at University of Colorado School of Medicine and associate director of the Colorado University Medicine Weight ...

BELLEVUE, Wash., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Truveta’s groundbreaking study analyzing real-world use of GLP-1 receptor agonist (GLP-1 RA) therapies in adults with overweight or obesity has ...

You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...

Josh Gad has opened up for the first time about using GLP-1 medication for weight loss and his seesaw experience with the positive and negative side effects. The actor and "Frozen" star spoke with ...

Kerry, a global business in taste and nutrition, has outlined five distinct consumer segments among those who consume GLP-1s, each with unique preferences and needs, providing a framework for future ...

Dr. Solow brings more than 30 years of experience in healthcare, including obesity care, clinical research, and the integration of GLP-1 medications into sustainable weight-loss treatments.

Share on Pinterest Zepbound is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) drug. You inject the drug into your stomach, thigh, or upper arm.

Your alcohol tolerance will be lower when taking GLP-1s "because you’re consuming fewer calories per day, so it’s almost akin to drinking on an empty stomach,” Kahn explains. Additionally ...

Does GLP-1RA use impact the risk of thyroid cancer? GLP-1RAs are highly effective medications used to treat T2D and obesity while simultaneously conferring protection against cardiovascular ...